Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Lars Ditlev ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   4.1% 5.7% 6.2% 6.6% 6.9% 8.5% 7.1% 7.1%   Credit score (0-100)   51 41 38 35 34 28 34 34   Credit rating   BBB BBB BBB BBB BBB BB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,035 955 -99.0 -302 -207 -225 0.0 0.0   EBITDA   787 -50.7 -934 -936 -858 -858 0.0 0.0   EBIT   622 -209 -1,094 -1,103 -1,241 -1,300 0.0 0.0   Pre-tax profit (PTP)   497.1 667.8 337.0 384.1 144.6 -29.3 0.0 0.0   Net earnings   387.8 520.8 264.1 291.2 112.7 -23.5 0.0 0.0   Pre-tax profit without non-rec. items   497 668 337 384 145 -29.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   350 694 637 532 2,148 1,825 0.0 0.0   Shareholders equity total   624 1,092 1,302 1,573 1,629 1,546 1,435 1,435   Interest-bearing liabilities   1,085 0.0 0.0 0.0 1,265 1,027 0.0 0.0   Balance sheet total (assets)   2,679 2,087 2,502 2,597 4,012 3,724 1,435 1,435   Net Debt   324 -70.6 -460 -276 827 521 -572 -572     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,035 955 -99.0 -302 -207 -225 0.0 0.0   Gross profit growth   96.3% -53.1% 0.0% -204.5% 31.3% -8.4% 0.0% 0.0%   Employees   0 0 0 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,679 2,087 2,502 2,597 4,012 3,724 1,435 1,435   Balance sheet change%   31.7% -22.1% 19.9% 3.8% 54.5% -7.2% -61.5% 0.0%   Added value   787.0 -50.7 -934.4 -935.9 -1,073.5 -858.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -269 154 -274 -335 1,170 -829 -1,825 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 -3.0 -4.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   30.5% -21.8% 1,104.7% 365.9% 598.6% 578.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   26.4% 31.8% 18.3% 20.4% 8.7% 2.6% 0.0% 0.0%   ROI %   36.5% 48.8% 30.3% 31.5% 11.6% 3.3% 0.0% 0.0%   ROE %   90.1% 60.7% 22.1% 20.3% 7.0% -1.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   23.3% 52.3% 52.0% 60.6% 40.6% 41.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   41.1% 139.2% 49.3% 29.5% -96.4% -60.7% 0.0% 0.0%   Gearing %   173.8% 0.0% 0.0% 0.0% 77.7% 66.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.6% 16.4% 0.0% 0.0% 22.4% 11.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.1 0.3 0.8 1.3 0.4 0.5 0.0 0.0   Current Ratio   1.1 0.3 0.8 1.3 0.4 0.5 0.0 0.0   Cash and cash equivalent   761.5 70.6 460.2 276.3 437.7 506.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   109.4 -547.0 -194.8 267.2 -1,189.1 -890.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 -936 -1,073 -858 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 -936 -858 -858 0 0   EBIT / employee   0 0 0 -1,103 -1,241 -1,300 0 0   Net earnings / employee   0 0 0 291 113 -24 0 0